Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Preventative effect of TSPO ligands on mixed antibody-mediated rejection through a Mitochondria-mediated metabolic disorder

Fig. 2

TSPO ligands reduce the proliferation and activation of B cells Purified CD19+ B cells were stimulated with CpG + anti-IgM, CpG + anti-IgM + FGIN1-27, or CpG + anti-IgM + Ro5-4864, for 2 days. A, D Representative bromodeoxyuridine expression and bar graphs of flow-cytometry data. B, E and (C, F) Representative expression of CD69 and CD25 and bar graphs of flow-cytometry results. Data are the mean ± SD of five independent samples. n = 5; *P < 0.05; **P < 0.01

Back to article page